Results 61 to 70 of about 154,948 (311)

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić   +8 more
wiley   +1 more source

INSULIN INITIATION IN T2DM

open access: yesJournal of the ASEAN Federation of Endocrine Societies
INTRODUCTIONThe prevalence of diabetes in Malaysia is rising due to urbanization and socioeconomic changes. Despite evidence supporting good glycaemic control, maintaining optimal control remains challenging, with mean HbA1c levels ranging from 7.9% to 8.1%.
Ooi Chuan Ng, Jo-An Ng
openaire   +1 more source

Comparison of Imaging features of T2DM MDR-TB, T2DM DS-TB and pure DS-TB cases.

open access: yes, 2016
Comparison of Imaging features of T2DM MDR-TB, T2DM DS-TB and pure DS-TB cases.
Guoqing Zhang (151441)   +4 more
core   +1 more source

Type 2 diabetes mellitus (T2DM) onset and remission . [PDF]

open access: yes, 2016
Background: Type 2 diabetes mellitus (T2DM) is a progressive disease condition. As the disease progresses the function of beta (β) cells (cells which regulate insulin) decline, thereby increasing the circulating blood glucose levels.
Tangelloju, Srikanth
core   +1 more source

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad   +4 more
wiley   +1 more source

The Neutrophil-To-Lymphocyte Ratio as an Associated Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus. [PDF]

open access: yesJ Clin Lab Anal
Type 2 diabetes mellitus (T2DM) is associated with chronic low‐grade systemic inflammation. This study evaluated the neutrophil‐to‐lymphocyte ratio (NLR) as a practical inflammatory biomarker in T2DM. A cross‐sectional study was conducted in Hodeidah City among 82 participants: 42 T2DM patients and 40 healthy controls.
Alkhadem YAD   +6 more
europepmc   +2 more sources

Sleeve gastrectomy: an ideal choice for T2DM [PDF]

open access: yesNature Reviews Endocrinology, 2013
As Ricardo Cohen pointed out (Sleeve gastrectomy: the ideal option for meta‐ bolic surgery? Nat. Rev. Endocrinol. 9, doi:10.1038/nrendo.2013.100‐c1)1 concern‐ ing my News and Views article (Sleeve gas‐ trectomy—the ideal choice for weight‐loss surgery. Nat. Rev. Endocrinol.
openaire   +2 more sources

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed   +7 more
wiley   +1 more source

ROC curve analysis for SOST and irisin in T2DM+ATHR and T2DM-ATHR groups.

open access: yes, 2018
ROC curve analysis for SOST and irisin in T2DM+ATHR and T2DM-ATHR groups.
Ibrahim Ali Emara (5942729)   +4 more
core   +1 more source

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy